284 related articles for article (PubMed ID: 32349929)
21. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
22. Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.
Majewski T; Yao H; Bondaruk J; Chung W; Lee S; Lee JG; Zhang S; Cogdell D; Yang G; Choi W; Dinney C; Grossman HB; Logothetis C; Scherer SE; Guo CC; Zhang L; Wei P; Weinstein JN; Issa JP; Baggerly K; McConkey DJ; Czerniak B
Cell Rep; 2019 Feb; 26(8):2241-2256.e4. PubMed ID: 30784602
[TBL] [Abstract][Full Text] [Related]
23. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
[TBL] [Abstract][Full Text] [Related]
24. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
26. Mutational spectra at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in T-lymphocytes of nonsmoking and smoking lung cancer patients.
Hackman P; Hou SM; Nyberg F; Pershagen G; Lambert B
Mutat Res; 2000 Jun; 468(1):45-61. PubMed ID: 10863157
[TBL] [Abstract][Full Text] [Related]
27. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
[TBL] [Abstract][Full Text] [Related]
28. The origins of bladder cancer.
Crawford JM
Lab Invest; 2008 Jul; 88(7):686-93. PubMed ID: 18475256
[TBL] [Abstract][Full Text] [Related]
29. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
30. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P
Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884
[TBL] [Abstract][Full Text] [Related]
31. Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
Qiu JG; Shi DY; Liu X; Zheng XX; Wang L; Li Q
J Cell Physiol; 2019 May; 234(5):6976-6982. PubMed ID: 30317582
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
[TBL] [Abstract][Full Text] [Related]
33. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
Scherr DS
Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
35. Genomic case report of a low grade bladder tumor metastasis to lung.
Van Every MJ; Dancik G; Paramesh V; Gurda GT; Meier DR; Cash SE; Richmond CS; Guin S
BMC Urol; 2018 Sep; 18(1):74. PubMed ID: 30176882
[TBL] [Abstract][Full Text] [Related]
36. Exposure of primary porcine urothelial cells to benzo(a)pyrene: in vitro uptake, intracellular concentration, and biological response.
Verma N; Pink M; Petrat F; Rettenmeier AW; Schmitz-Spanke S
Arch Toxicol; 2012 Dec; 86(12):1861-71. PubMed ID: 22790669
[TBL] [Abstract][Full Text] [Related]
37. Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells.
Severson PL; Vrba L; Stampfer MR; Futscher BW
Mutat Res Genet Toxicol Environ Mutagen; 2014 Dec; 775-776():48-54. PubMed ID: 25435355
[TBL] [Abstract][Full Text] [Related]
38. Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer.
Wong K; Abascal F; Ludwig L; Aupperle-Lellbach H; Grassinger J; Wright CW; Allison SJ; Pinder E; Phillips RM; Romero LP; Gal A; Roady PJ; Pires I; Guscetti F; Munday JS; Peleteiro MC; Pinto CA; Carvalho T; Cota J; Du Plessis EC; Constantino-Casas F; Plog S; Moe L; de Brot S; Bemelmans I; Amorim RL; Georgy SR; Prada J; Del Pozo J; Heimann M; de Carvalho Nunes L; Simola O; Pazzi P; Steyl J; Ubukata R; Vajdovich P; Priestnall SL; Suárez-Bonnet A; Roperto F; Millanta F; Palmieri C; Ortiz AL; Barros CSL; Gava A; Söderström ME; O'Donnell M; Klopfleisch R; Manrique-Rincón A; Martincorena I; Ferreira I; Arends MJ; Wood GA; Adams DJ; van der Weyden L
Genome Biol; 2023 Aug; 24(1):191. PubMed ID: 37635261
[TBL] [Abstract][Full Text] [Related]
39. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene.
Feng Z; Hu W; Rom WN; Beland FA; Tang MS
Carcinogenesis; 2002 Oct; 23(10):1721-7. PubMed ID: 12376482
[TBL] [Abstract][Full Text] [Related]
40. A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer.
Fantini D; Glaser AP; Rimar KJ; Wang Y; Schipma M; Varghese N; Rademaker A; Behdad A; Yellapa A; Yu Y; Sze CC; Wang L; Zhao Z; Crawford SE; Hu D; Licht JD; Collings CK; Bartom E; Theodorescu D; Shilatifard A; Meeks JJ
Oncogene; 2018 Apr; 37(14):1911-1925. PubMed ID: 29367767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
